European Pharmaceutical Review

FEBRUARY 27, 2024

It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceutical Companies FDA 100

Pharmaceutical Technology

APRIL 12, 2024

Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.

98

98

Drug Store News

MARCH 4, 2024

Sandoz is closing the Fougera manufacturing and packaging facilities located in Melville and Hicksville on Long Island, N.Y.

Packaging 111

Packaging 111

Pharmafile

FEBRUARY 27, 2024

This will be the latest development in the company’s global operations as well as its most advanced facility at present. The facility is approximately 300,000 ft2 and is expected to employ 400 full-time staff.

68

68

European Pharmaceutical Review

DECEMBER 21, 2023

Piramal Pharma Solutions has officially opened new facilities at its antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland. We see the market gravitating towards large and commercial scale manufacturing, which the new facility is well equipped to address,” he added.

88

88

European Pharmaceutical Review

NOVEMBER 24, 2023

Novo Nordisk’s multi-billion facility expansion This financial commitment will greatly strengthen manufacturing capacity, more than doubling the site’s footprint. As “a future-proof and cost-effective facility”, Novo Nordisk stated that it will reduce water consumption by 25 percent compared to current production lines.

Packaging 96

Packaging 96

Pharmafile

FEBRUARY 22, 2024

BioAscent has announced that it has opened its new state-of-the-art protein production facility in an event chaired by Professor Michael Barrett OBE.

58

58

Drug Store News

FEBRUARY 9, 2024

Empower Pharma is expected to use the facility to expand its 503A, 503B and contract development and manufacturing organization operations for the pharmaceutical industry.

105

105

European Pharmaceutical Review

SEPTEMBER 12, 2023

A new state-of-the-art manufacturing facility for microbiome ecosystem therapies has now completed construction. The new facility was completed within 12 months, according to David Lescuyer, CEO and President of Skyepharma. The post Microbiome therapy manufacturing facility completed appeared first on European Pharmaceutical Review.

92

92

European Pharmaceutical Review

SEPTEMBER 21, 2023

A new Denmark-based manufacturing facility is set to establish the final development steps and upscaling of cell therapies. Partly due to this and due to the explorative phase cell therapy is in, it is very expensive to develop and manufacture cell therapies, so there simply are not many facilities doing it.”

Hospitals 109

Hospitals 109

Pharmaceutical Technology

MARCH 13, 2024

Bright Green has announced plans to expand its controlled substances drug production facility in New Mexico, US with an investment of $250m.

Controlled Substances 97

Controlled Substances 97

European Pharmaceutical Review

DECEMBER 15, 2023

Alkermes has agreed to sell its pharmaceutical development and manufacturing facility in Athlone, Ireland to Novo Nordisk for $92.5 Additionally, Alkermes and Novo Nordisk plan to agree subcontracting arrangements to continue certain work currently performed at the facility, potentially until the end of 2025.

84

84

Pharmaceutical Technology

FEBRUARY 7, 2024

AstraZeneca is investing $300m in a facility in Rockville, US - a significant step in launching its cell therapy platforms in the country.

97

97

Drug Store News

FEBRUARY 9, 2024

Empower Pharma is expected to use the facility to expand its 503A, 503B and contract development and manufacturing organization operations for the pharmaceutical industry.

94

94

OctariusRx

JUNE 26, 2023

Is your facility DEA compliant? What would your facility do without a controlled substance license? If your facility does not strictly adhere to DEA requirements, in addition to the legal and regulatory risk, you are potentially endangering your patients. The post Is your facility DEA compliant? Can you afford a fine?

Controlled Substances 72

Controlled Substances 72

pharmaphorum

JANUARY 25, 2024

UK government is reported to be considering financial aid for AstraZeneca to seal a deal to expand a vaccines manufacturing facility in Speke

Vaccines 102

Vaccines 102

European Pharmaceutical Review

JULY 8, 2022

As established facilities age, various risk considerations emerge. While some risks related to the processes and facilities becoming obsolete or incremental modifications over time making production less efficient, he also included microbial contamination concerns, which will be the focus of this summary.

123

123

Pharmaceutical Technology

DECEMBER 21, 2023

Genevoyager has announced the opening of contract development and manufacturing organisation facility to manufacture gene therapy products.

97

97

Outsourcing Pharma

MARCH 6, 2024

Almac Group, a global leader in CDMOs, announced today (March 6) that it has unveiled two new purpose-built facilities at its headquarters in Northern Ireland.

110

110

Fierce Pharma

JANUARY 4, 2024

Already with a manufacturing site in Chiba, Japan, AGC Biologics is doubling down on its presence in the country with a new facility in Yokohama. Already with a manufacturing site in Chiba, Japan, AGC Biologics is doubling down on its presence in the country with a new facility in Yokohama.

94

94

European Pharmaceutical Review

OCTOBER 17, 2023

The US Food and Drug Administration (FDA) has published draft guidance on how it intends to use alternative tools for assessing drug manufacturing facilities identified in pending marketing applications. Fundamentally, this approach will establish whether facilities meet applicable requirements for FDA approval and licensure decisions.

FDA 93

FDA Communication Packaging 93

ISPE

FEBRUARY 17, 2023

Key among these included a presentation by the director of FDA’s CBER on cell and gene therapy manufacturing and a range of considerations behind new facility planning from a Janssen Pharmaceuticals executive whose company has been paving the road ahead with its facilities. The facility does a lot of multivariate analysis.

FDA 98

FDA Vaccines 98

BioPharm

APRIL 22, 2024

At INTERPHEX 2024, a panel of experts gave insight on new regulatory requirements for contamination control and provided advice for how to implement a contamination control strategy in existing facilities.

59

59

Pharmaceutical Technology

NOVEMBER 24, 2023

Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.

105

105

BioPharm

APRIL 16, 2024

This investment will bolster the company’s large-scale cell culture CDMO business at its planned Fujifilm Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina.

59

59

Fierce Pharma

FEBRUARY 26, 2024

Amgen is now open for business in Central Ohio after cutting the ribbon at its “most advanced facility to date.” | Amgen is now open for business in Central Ohio after cutting the ribbon at its “most advanced facility to date.”

102

102

Pharmafile

JANUARY 3, 2024

Proteome Sciences has announced that it has completed the installation and set up of equipment in its new laboratory facility in San Diego, US, meaning it is now fully operational.

58

58

pharmaphorum

NOVEMBER 23, 2023

US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and therapeutics, part of a 10-year partnership with the government agreed last year that has been estimated to be worth around £1 billion.

Vaccines 99

Vaccines 99

Fierce Healthcare

JUNE 22, 2023

Physician-owned general acute care hospitals charge less than other non-physician-owned facilities in their region for several common shoppable care services, according to a new analysis published | A new analysis of competing hospitals' published prices adds fuel to the debate over whether Congress should lift the Affordable Care Act's ban (..)

Hospitals 143

Hospitals 143

European Pharmaceutical Review

JUNE 9, 2023

Telix Pharmaceuticals has opened a new radiopharma production facility in the Wallonia region of Belgium, which will serve as the company’s primary manufacturing site for radioisotopes and commercial and clinical products. Telix is also preparing to install the first of two planned cyclotrons for the radiopharma production facility.

83

83

Fierce Healthcare

APRIL 10, 2024

The real estate deal for facilities in California and New Jersey came alongside a new lease agreement and purchase option for the remaining four hospitals owned by Medical Properties Trust.

Hospitals 67

Hospitals 67

BioPharm

NOVEMBER 15, 2023

As oligo manufacturers scale up production from lab-scale to clinical and commercial scales, they may require volumes of hazardous materials that drive additional facility design considerations.

52

52

Outsourcing Pharma

SEPTEMBER 18, 2023

The Japanese firm Astellas Pharma will apply for planning permission to construct a drug manufacturing facility in Tralee, Co. Kerry, Ireland worth around â330 million ($352 million).

98

98

Pharmaceutical Technology

DECEMBER 21, 2022

Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. Planned to be operational by 2025, the construction of the facility is anticipated to begin early next year.

Vaccines 140

Vaccines Communication 140

European Pharmaceutical Review

SEPTEMBER 13, 2023

Following a UK Medicines & Healthcare Products Regulatory Agency (MHRA) inspection, Rentschler Biopharma SE’s UK advanced therapy medicinal products (ATMP) facility has received a current good manufacturing practice (cGMP) Manufacturing Compliance Certificate.

82

82

Pharmafile

MARCH 6, 2023

US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is already home to more than 70 organisations and sits within the UK’s ‘golden triangle’, an area rich in life sciences facilities, between Oxford, Cambridge and London.

Vaccines 93

Vaccines 93

European Pharmaceutical Review

FEBRUARY 3, 2023

Switzerland-based contract development and manufacturing organisation (CDMO) CARBOGEN AMCIS has opened a new facility in France, dedicated to the custom development and production of sterile injectable drug products. The 9,500m 2 facility will harness state-of-the-art containment technologies, Baduel confirmed.

Dosage 93

Dosage Compounding Pharmaceutical Companies Pharmaceutical Companies 93